EPTIS
BAM Logo

Therapeutic Drug Scheme - (TDM)

EPTIS factsheet 142075 | Last revision 2016-05-19 | URL: https://www.eptis.bam.de/pts142075 https://www.eptis.bam.de/pts142075

PT provider
PT provider LGC Standards Proficiency Testing LGC Standards Proficiency Testing
Based in United Kingdom
Language(s)
Remarks
Keywords
Product groups Pharmaceutical products, drugs
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Therapeutic drugs mixture: Human serum Caffeine -
Carbamazepine -
Carbamazepine (CBZ) epoxide -
CBZ-epoxide -
Clonazepam -
Digoxin -
Ethosuximide -
Lamotrigine -
Lithium -
Methotrexate -
Phenobarbitone -
Phenytoin -
Primidone -
TD- Amikacin -
TD-Gentamicin -
TD-Tobramycin -
TD-Vancomycin -
Theophylline -
Valproate -
Other therapeutic drugs: Human serum Clobazam -
Norclobazam -
Anti-epileptic drugs AE1 mixture: Human serum Gabapentin -
Levetiracetam -
OH-oxcarbazepine -
Pregabalin -
Tiagabine -
Anti-epileptic drugs AE2 mixture: Human serum Felbamate -
Lacosamide -
Rufinamide -
Topiramate -
Vigabatrin -
Zonisamide -
Anti-epileptic drugs AE3* mixture: Human serum Retigabine (Ezogabine) -
Anti-epileptic drugs AE4* mixture: Human serum Perampanel -
Cardiac drugs mixture: Human serum Amiodarone -
Desethylamiodarone -
Flecainide -
Drugs used for the treatment of substance related disorders 1 Buprenorphine -
Norbuprenorphine -
Drugs used for the treatment of substance related disorders 2 Methadone -
EDDP -
Psychoactive drugs: Newborn calf serum Amitriptyline; Nortriptyline -
Imipramine; Desipramine -
Clomipramine; Norclomipramine -
Clozapine; Norclozapine -
Doxepin; Nordoxepin -
Fluoxetine; Norfluoxetine -
Fluphenazine -
Sertraline; Norsertraline -
Trimipramine; Nortrimipramine -
Risperidone; HO-risperidone -
Mirtazapine; Normirtazapine -
Maprotiline; Normaprotiline -
Thioridazine -
Haloperidol -
Perphenazine -
Quetiapine; Norquetiapine -
Citalopram; Norcitalopram -
Dothiepin; Northiaden -
Venlafaxine; Norvenlafaxine -
Paroxetine -
Fluvoxamine -
Zuclopenthixol -
Amisulpride -
Aripiprazole; Dehydroaripiprazole -
Ziprasidone -
Duloxetine -
Escitaloprame -
Trazodone -
Sulpiride -
*Chlorpromazine; Norchlorpromazine -
Psychoactive drugs: Human serum Olanzapine -
Smoking related drugs: Human urine Nicotine -
Cotinine -
Antibiotic drugs: Human serum Gentamicin;Vancomycin -
Tobramycin -
Amikacin -
Netilmicin -
Chloramphenicol -
Flucytosine -
Teicoplanin -
Immunosuppressive drugs: Human blood/plasma Cyclosporin -
Everolimus -
Mycophenolate -
Sirolimus -
Tacrolimus -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards ISO 15189: 2003
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043 Please see current application form and scheme description for accredited and non-accredited status of test materials and analytes.

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Depending on samples taken
Regularly operated Yes (12 rounds per annum)
Year of first operation 1972
Contact details of the PT provider
Provider Contact person
LGC Standards Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green,
BL9 0AP Bury Lancashire
United Kingdom

Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Web: http://www.lgcstandards.com http://www.lgcstandards.com
Mr Savvas Xystouris
Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Email: savvas.xystouris@lgcgroup.com savvas.xystouris@lgcgroup.com
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21